As of 2024-12-14, the Relative Valuation of Accelerate Diagnostics Inc (AXDX) is (76.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 USD, the upside of Accelerate Diagnostics Inc based on Relative Valuation is -5784.9%.
The range of the Relative Valuation is (80.27) - (76.30) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 37.6x - 41.3x | 38.9x |
| Forward P/E multiples | 30.5x - 35.7x | 33.0x |
| Fair Price | (80.27) - (76.30) | (76.75) |
| Upside | -6045.8% - -5751.6% | -5784.9% |
| Date | P/E |
| 2024-12-13 | -0.64 |
| 2024-12-12 | -0.63 |
| 2024-12-11 | -0.62 |
| 2024-12-10 | -0.67 |
| 2024-12-09 | -0.70 |
| 2024-12-06 | -0.74 |
| 2024-12-05 | -0.74 |
| 2024-12-04 | -0.80 |
| 2024-12-03 | -0.74 |
| 2024-12-02 | -0.77 |
| 2024-11-29 | -0.78 |
| 2024-11-27 | -0.75 |
| 2024-11-26 | -0.77 |
| 2024-11-25 | -0.77 |
| 2024-11-22 | -0.77 |
| 2024-11-21 | -0.78 |
| 2024-11-20 | -0.80 |
| 2024-11-19 | -0.82 |
| 2024-11-18 | -0.84 |
| 2024-11-15 | -0.87 |
| 2024-11-14 | -0.88 |
| 2024-11-13 | -0.89 |
| 2024-11-12 | -0.92 |
| 2024-11-11 | -0.89 |
| 2024-11-08 | -0.86 |
| 2024-11-07 | -0.92 |
| 2024-11-06 | -0.93 |
| 2024-11-05 | -0.94 |
| 2024-11-04 | -0.88 |
| 2024-11-01 | -0.90 |
| 2024-10-31 | -0.90 |
| 2024-10-30 | -0.88 |
| 2024-10-29 | -0.87 |
| 2024-10-28 | -0.88 |
| 2024-10-25 | -0.88 |
| 2024-10-24 | -0.83 |
| 2024-10-23 | -0.84 |
| 2024-10-22 | -0.87 |
| 2024-10-21 | -0.87 |
| 2024-10-18 | -0.85 |
| 2024-10-17 | -0.82 |
| 2024-10-16 | -0.89 |
| 2024-10-15 | -0.88 |
| 2024-10-14 | -0.81 |
| 2024-10-11 | -0.82 |
| 2024-10-10 | -0.86 |
| 2024-10-09 | -0.86 |
| 2024-10-08 | -0.90 |
| 2024-10-07 | -0.88 |
| 2024-10-04 | -0.91 |